Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-127-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Reliance on read-across data from long-term testing of sulphuric acid on vertebrate animals is considered appropriate because the multi-constituent test material consists of > 80 % sulphuric acid, is designed to be highly corrosive, and is used only under industrial conditions where risk management measures and suitable training can be expected. As such, human exposure via the inhalation or dermal routes is unlikely under normal operating conditions and oral exposure can be discounted on the grounds of good industrial hygiene.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - systemic effects
Link to relevant study records
- Endpoint:
- chronic toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
The reaction mass of sulphuric acid, hydrogen peroxide and peroxomonosulphuric acid is predominantly sulphuric acid (>80%). Although all constituents of the reaction mass contribute towards and are essential for the desired technical effects of the range, it is considered acceptable to read-across to data on sulphuric acid. This because significant toxicological effects are likely to be masked in the multi-constituent substance by its corrosive nature and so it considered appropriate to read across to the mean constituent, sulphuric acid, when considering long-term inhalation toxicity.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
See read-across data matrix under 'Attached background material' below.
3. ANALOGUE APPROACH JUSTIFICATION
See read-across data matrix under 'Attached background material' below.
4. DATA MATRIX
See read-across data matrix under 'Attached background material' below. - Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Groups of cynomolgus monkeys were exposed to mixtures of sulphur dioxide, fly ash and sulphuric acid mist.
- GLP compliance:
- no
- Remarks:
- Study pre-dates GLP
- Limit test:
- no
- Species:
- primate
- Strain:
- other: Cynomolgus (Macaca irus)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Young cynomolgus monkeys wighing 1.9 to 5.3 kg were individually caged and held in a quarantine area for eight weeks.
- Animals were tested twice for tuberculosis during the quarantine period and then transported to laboratory animal holding rooms where they were observed for a period of two weeks.
- During the following 8 to 12 weeks, animals were re-tested for tuberculosis and a chest roentgenogrph was taken.
- Animals were screened via evaluation of pulmonary function, electrocardiogram, haemotologic testing and chemical analyses.
- Animals exibiting normal values were accepted.
- During this period, animals were also placed in a restraining chair with face mask to adapt them to pulmonary function testing procedures.
- Animals accepted for studies were then transferred to individual exposure cages and placed in stainless steel and glass chambers.
- Air supplied to each exposure chamber passed through a charcoal bed and absolute filter.
- Temperature was maintained at 22.2 ± 1.1 °C.
- Relative humidity was maintained at 50 ± 5 %
- Airflow through each chamber was slightly in excess of 1000 L/min. - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: water
- Remarks on MMAD:
- MMAD / GSD: Mass Median Diameter 0.5 to 3.35 μm (sulphuric acid)
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- SULPHUR DIOXIDE
- Instruments were calibrated against a published wet chemical method.
- For groups exposed to mixtures of sulphur dioxide and sulphuric acid mist, sulphur dioxide was sampled daily with an impinger at the chamber inlet, prior to mixing with sulphuric acid, and analysed by the wet chemical method to check concentration.
- Prior experimentation verified that the resulting sulphur dioxide concentration was the same at the chamber air inlet and in the chamber.
- For the group exposed to sulphur dioxide alone (group 2), samples of chamber air were taken daily and analysed by the wet chemical method.
SULPHURIC ACID MIST
- Samples of each chamber's atmosphere was collected once daily on a glass-fibre filter and analysed according to the turbidimetric method during the absence of sulphur dioxide and ash in the chambers.
- Particle size measurements were performed with a cascade impactor.
- Mass median diameter was calculated using a published method.
- Determinations were made during the absence of fly ash in the chambers.
FLY ASH
- Chamber samples were obtained daily with a glycerin-filled impinger and the suspensions were analysed for fly ash concentration by standard spectrophotometry.
- Particle size analysis was performed with a multiple stage aero-dynamic particle sizer.
- Mass median diameter was calculated by standard methods.
- Samples were also obtained for examination by light or electron microscopy.
- Determinations were made during exclusion of sulphuric acid mist from the chambers. - Duration of treatment / exposure:
- Animals were exposed for 22 to 23 hours per day for 78 weeks
- Frequency of treatment:
- Daily
- Remarks:
- Doses / Concentrations:
0.1 to 1 mg/m3
Basis:
analytical conc. - No. of animals per sex per dose:
- Nine animals (five males and four females or vice versa)
- Control animals:
- yes, sham-exposed
- Details on study design:
- - After the animals were placed in the exposure chamber, a period of two weeks was allowed for adaptation.
- During the following eight weeks, all groups were exposed to filtered air and physiological measurements were made to establish base line values and normal week to week variations.
- Exposure to sulphur dioxide, sulphuric acid mist and fly ash mixtures was then initiated and continued for a period of 18 months.
- The exposure was interrupted twice each day to permit feeding of the animals and cleaning of the chambers.
- Exposures were also interrupted for the duration of the particular test on days when physiological measurements were made.
- When mixtures of sulphur dioxide and sulphuric acid were used, interruption of one agent or other was also made from time to time to permit verification of analytical concentrations. - Observations and examinations performed and frequency:
- - Body weights were recorded weekly during the 8 week pre-exposure period and during the 78 weeks of exposure.
- Observation for survival and gross signs of behavioural abnormality were made daily.
- Regular pulmonary function tests included measurement of mechanical properties of the lung (weekly during pre-exposure period and the first nine weeks of exposure, and then every four weeks). Diffusing capacity of the lung was also tested (five times during the pre-exposure period, every two weeks for the first ten weeks of exposure, and then every four weeks).
- Lung tests were performed without anaesthesia and after removal of the animals from the exposure chamber. The animals were placed in a sitting position in a restraining chair and allowed to adapt to the face mask attachment for 10 to 20 minutes. - Sacrifice and pathology:
- - Animals were killed with an overdose of pentobarbital sodium followed by exsanguination.
- Complete necropsies were performed on each animal.
- The trachae, peribronchial lymph nodes, heart, liver and kidneys were taken and fixed in 10% neutral buffered formaldehyde solution. Six-micron hematoxylin-eosin stained slides were then prepared.
- The lungs were removed from animals in an inflated state and perfused intratracheally with a volume of 10 % neutral buffered formaldehyde solution equal to the tidal volume of the animal. Slides were prepared from each of the seven lobes of the lungs. - Other examinations:
- - Arterial blood was obtained from the femoral artery for measurements of oxygen tension, carbon dioxide tension and acidity. Each sample of blood was obtained 10 to 20 minutes after injection of phencyclidine hydrochloride for tranquilisation of the animal.
- Blood obtained from the femoral artery was used to determine hematocrit, haemoglobin, total erythrocyte and leucocyte counts, lymphocytes, segmented neutrophils, blood urea nitrogen, total bilirubin, serum total protein, serum albumin, serum glutamic oxaloacetic transaminase (SGOT), serum glutamicpyruvic transaminase (SGPT), serum lactic acid dehydrogenase (LDH), and serum alkaline phosphatase. Determinations were made once during the pre-exposure period and at weeks 11, 16, 25, 49 and 77 of the exposure period. - Statistics:
- - All data were stored and analysed using a digital computer system.
- Regression analysis techniques were used on the measured functions when sufficient data points (> 8) were available.
- Comparisons of the regression coefficients between groups were made by t-test and confidence intervals were calculated.
- In all cases P < 0.05 was chosen for accepting or rejecting differences between groups as significant. - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- One death in the control group of set A and one death in Group 3 of set A (neither death was considered to be related to exposure to the pollutants)
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- One death in the control group of set A and one death in Group 3 of set A (neither death was considered to be related to exposure to the pollutants)
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Considerable variation in SGOT, SGPT, LDH and alkaline phosphatase were observed during the exposure period in all groups of monkeys but no trend indicating possible effects from the exposures were observed
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Fly ash was deposited peribronchially, perivascularly and in the alveolar septa in the lungs. Fly ash particles had been phagocytised and, with the exception of occasional focal alveolitis, no significant reaction was associated with particle deposition.
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Exposure related microscopic alterations observed in the lungs
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- - With the exception of results obtained with measurements of pulmonary flow resistance (R1) and distribution of ventilation, no other measured functions changed as the result of exposure, and only variations normally presented by unexposed control animals were observed.
- Increases in pulmonary flow resistance could not be definitely attributed to exposure conditions.
- Results for distribution of ventilation, measured by the nitrogen washout technique, demonstrated a significant increase in the number of breaths to washout 1 % nitrogen, only in group 12 and was not considered to indicate a detrimental effect because the group began the study with significantlylower values than monkeys in group 1 or group 15.
- Incidental microscopic alterations were present in tissues from the control animals of groups 1 and 9 as well as from all exposed groups.
- Exposure related microscopic alterations were observed in the lungs in groups 4, 10 and 16. In group 10, exposed to 0.99 ppm sulphur dioxide and 0.93 mg/m3 of sulphuric acid mist, the microscopic alterations were characterised by changes in the bronchial mucosa. In some areas of the bronchial tree, focal goblet cell hypertrophy and occasionally hyperplasia were seen; whereas, in other areas of the bronchial tree, the mucosa was thinner thn normal and possessed focal areas of squamous metaplasia. In goup 16, exposed to approximately the same concentrations of sulphur dioxide and sulphuric acid mist as group 10, plus 0.41 mg/m3 fly ash, the same alterations were present.
- In group 4, exposed to 0.99 mg/m3 of sulphuric acid mist and 0.55 mg/m3 of fly ash, microscopic alterations were characterised primarily by changes in the mucosa of the bronchi and respiratory bronchioles. Focal areas of erosion were present in these conducting areas as were focal areas of epithelial hypertrophy and hyperplasia. The severity of these alterations was generally slight. The walls of the bronchi were occasionally thickened and in some instances the airways were ectatic.
- The addition of fly ash to the binary combination of sulphur dioxide and sulphuric acid did not increase the severity of the microscopic alterations over that seen in the lungs from monkeys exposed to the binary combination.
- No detrimental effect had been detected in previous work when cynomolgus monkeys underwent long-term exposure to sulphur dioxide from 0.1 to 5 ppm.
- No detrimental effect had been detected in previous work with exposure of cynomolgus monkeys to fly ash from 0.1 to 0.5 mg/m3.
- No detrimental effect had been detected in previous work when mixtures of sulphur dioxide and fly ash were investigated.
- Regardless of particle size, previous work demonstrated that exposure to sulphuric acid at concentrations above 2.5 mg/m3 induced definite pulmonary function impairment (pulmonary ventilation) in cynomolgus monkeys as well as histopathological effects. - Dose descriptor:
- LOAEC
- Effect level:
- 1 mg/m³ air
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
- Critical effects observed:
- not specified
- Conclusions:
- The authors conclude that deleterious effects detected from exposure to mixtures of sulphur dioxide, fly ash and sulphuric acid mist were attributable to the presence of the acid mist alone.
Reference
JUSTIFICATION FOR USE OF READ-ACROSS DATA
See comparison of overall physico-chemical and toxicity profiles for target and source chemicals in the data matrix (attached).
RESULTS FOLLOWING EXPOSURE OF CYNOMOLGUS MONKEYS TO VARIOUS AGENTS FOR 18 MONTHS
SET A |
|||||||
Group |
Initial Body Weight (kg) ± SE |
Agents |
Concentration* in mg/m3 for sulphuric acid and fly ash; ppm for sulphur dioxide |
Particle size MMD (μm) ** |
Range for geometric deviation of particle size determinations |
Deaths occurring during exposure |
Conclusion on effects of exposure |
1 |
3.1 ± 0.2 |
Filtered air |
- |
- |
- |
1 accidental |
- |
2 |
2.9 ± 0.2 |
SO2 |
5.12 ± 0.21 |
- |
- |
0 |
No detrimental effects detected |
3 |
3.0 ± 0.4 |
H2SO4 |
0.11 ± 0.09 |
0.75 ± 0.3 |
1.5-3.0 |
1 due to gastric tympany |
No detrimental effects detected |
Fly ash |
0.53 ± 0.29 |
4.11 ± 3.0 |
1.8-2.2 |
||||
4 |
3.0 ± 0.3 |
H2SO4 |
0.99 ± 0.29 |
0.64 ± 0.3 |
1.5-3.0 |
0 |
Detrimental effects detected |
Fly ash |
0.55 ± 0.38 |
5.34 ± 2.8 |
1.8-2.2 |
||||
5 |
3.3 ± 0.2 |
SO2 |
0.11 ± 0.01 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.10 ± 0.04 |
1.00 ± 0.3 |
1.4-2.8 |
||||
6 |
3.0 ± 0.3 |
SO2 |
1.04 ± 0.09 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.10 ± 0.03 |
0.53 ± 0.3 |
1.4-2.8 |
||||
7 |
3.3 ± 0.3 |
SO2 |
5.15 ± 0.26 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.11 ± 0.05 |
1.07 ± 0.1 |
1.4-2.8 |
||||
8 |
3.5 ± 0.3 |
SO2 |
5.23 ± 0.45 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.97 ± 0.28 |
0.52 ± 0.2 |
1.4-2.8 |
||||
* Mean ± SD of between 542 to 952 daily determinations during the 18 months of exposure |
|||||||
** Mean ± SD of between 8 to 82 determinations during the 18 months of exposure |
SET B |
|||||||
Group |
Initial Body Weight (kg) ± SE |
Agents |
Concentration* in mg/m3 for sulphuric acid and fly ash; ppm for sulphur dioxide |
Particle size MMD (μm) ** |
Range for geometric deviation of particle size determinations |
Deaths occurring during exposure |
Conclusion on effects of exposure |
9 |
3.1 ± 0.3 |
Filtered air |
- |
- |
- |
0 |
- |
10 |
3.4 ± 0.3 |
SO2 |
0.99 ± 0.22 |
- |
- |
0 |
Detrimental effects detected |
H2SO4 |
0.93 ± 0.26 |
0.50 ± 0.06 |
1.5-3.8 |
0 |
|||
11 |
3.2 ± 0.3 |
SO2 |
0.11 ± 0.05 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.11 ± 0.05 |
3.35 ± 1.26 |
1.5-5.2 |
0 |
|||
12 |
3.3 ± 0.3 |
SO2 |
0.89 ± 0.18 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.11 ± 0.05 |
3.11 ± 0.77 |
4.5-5.2 |
0 |
|||
13 |
3.1 ± 0.2 |
H2SO4 |
0.09 ± 0.06 |
2.58 ± 0.64 |
1.5-5.2 |
0 |
No detrimental effects detected |
Fly ash |
0.45 ± 0.17 |
5.89 ± 3.64 |
1.6-2.6 |
||||
14 |
3.2 ± 0.3 |
SO2 |
0.12 ± 0.04 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.10 ± 0.04 |
2.73 ± 0.54 |
1.5-5.2 |
||||
Fly ash |
0.46 ± 0.22 |
4.87 ± 3.12 |
1.6-2.6 |
||||
15 |
3.0 ± 0.2 |
SO2 |
0.84 ± 0.17 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.09 ± 0.04 |
2.37 ± 0.59 |
1.5-5.2 |
||||
Fly ash |
0.42 ± 0.18 |
4.92 ± 1.09 |
1.6-2.6 |
||||
16 |
3.3 ± 0.4 |
SO2 |
1.01 1.00 |
- |
- |
0 |
Detrimental effects detected |
H2SO4 |
0.88 ± 0.29 |
0.54 ± 0.10 |
1.5-3.8 |
||||
Fly ash |
0.41 ± 0.16 |
4.10 ± 0.96 |
1.8-2.8 |
||||
17 |
3.5 ± 0.4 |
SO2 |
0.11 ± 0.04 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.10 ± 0.03 |
0.71 ± 0.19 |
1.49-3.80 |
||||
Fly ash |
0.44 ± 0.18 |
5.24 ± 2.34 |
1.80-2.78 |
||||
18 |
3.1 ± 0.3 |
SO2 |
0.93 ± 0.22 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.09 ± 0.03 |
0.64 ± 0.29 |
1.49-5.80 |
||||
Fly ash |
0.48 ± 0.22 |
5.18 ± 3.12 |
1.80-2.78 |
||||
19 |
3.6 ± 0.2 |
SO2 |
5.29 ± 0.94 |
- |
- |
0 |
No detrimental effects detected |
H2SO4 |
0.10 ± 0.04 |
0.54 ± 0.23 |
1.49-3.80 |
||||
Fly ash |
0.44 ± 0.16 |
4.87 ± 1.90 |
1.80-2.78 |
||||
* Mean ± SD of between 542 to 952 daily determinations during the 18 months of exposure |
|||||||
** Mean ± SD of between 8 to 82 determinations during the 18 months of exposure |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LOAEC
- 1 mg/m³
- Study duration:
- chronic
- Species:
- monkey
- Quality of whole database:
- See comparison of overall physico-chemical and toxicity profiles for target and source chemicals in the data matrix attached to relevant endpoint records.
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for selection of repeated dose toxicity via oral route
- systemic effects endpoint:
The multi-constituent test material is used only under modern
industrial conditions where rigorous training and appropriate risk
management measures are expected to prevent contact and protect humans
from the corrosive effects of the substance. As a result, exposure of
humans via the oral route is unlikely under normal operating conditions,
and vertebrate animal testing is unnecessary.
Justification for selection of repeated dose toxicity inhalation -
systemic effects endpoint:
Any toxic symptoms are considered to be attributable to long-term
inhalation of a corrosive substance rather than a true systemic effect.
Hence, it is inappropriate to conduct testing on vertebrate animals and
mitigation measures are used to prevent exposure of humans in the
workplace.
Justification for selection of repeated dose toxicity inhalation -
local effects endpoint:
Sulphuric acid, peroxomonosulphuric acid and hydrogen peroxide are
each expected to contribute to the physico-chemical properties of the
multi-constituent substance. However, significant toxicological effects
are likely to be masked in the multi-constituent substance by its
corrosive nature. It is therefore considered appropriate to read-across
to the main constituent, sulphuric acid, when addressing long-term
inhalation toxicity.
Justification for selection of repeated dose toxicity dermal -
systemic effects endpoint:
Any toxic symptoms are likely to be attributable to long-term dermal
exposure to a corrosive substance rather than a true systemic effect.
Hence, it is inappropriate to conduct testing on vertebrate animals and
mitigation measures are used to prevent exposure of humans in the
workplace.
Justification for selection of repeated dose toxicity dermal - local
effects endpoint:
The multi-constituent test material is used only under modern
industrial conditions where rigorous training and appropriate risk
management measures are expected to prevent contact and protect humans
from the corrosive effects of the substance. As a result, exposure of
humans via the dermal route is unlikely under normal operating
conditions, and vertebrate animal testing is unnecessary.
Justification for classification or non-classification
The multi-constituent test material is designed to be highly corrosive, is classified as such, and is used only under industrial conditions where strict risk managment measures and a high standard of training are expected to prevent human exposure via the inhalation or dermal routes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.